Softgel Capsules Market Analysis and Forecast to 2031: By Application (Health Supplements and Pharmaceuticals), Sales Channel (Supermarket and Hypermarket, Pharmacy and Drug Store, and Online Provider), and Region
Softgel capsules are a type of dietary supplement that is encased in a soft, gel-like shell. These capsules are designed to be easy to swallow and to dissolve quickly in the stomach.
Softgel capsules are often used to deliver vitamins, minerals, and other nutrients to the body. They may also be used to deliver medications, such as those used to treat pain or to promote weight loss.
Softgel capsules are generally considered safe for most people. However, as with any dietary supplement, it is important to speak with a healthcare provider before taking them.
Key Trends
The softgel encapsulation market is growing at a rapid pace due to the many advantages that softgels offer over other drug delivery systems. Some of the key trends in softgel capsules technology include:
1. Increased use of softgels for oral delivery of drugs: Softgels offer many advantages over tablets and capsules for oral drug delivery, including improved bioavailability, better patient compliance, and more. As a result, more and more drugs are being formulated as softgels.
2. Increased use of softgels for other delivery methods: In addition to oral delivery, softgels can also be used for topical, transdermal, and injectable drug delivery. This versatility makes them an attractive option for a variety of different drugs.
3. Improved manufacturing processes: Softgel manufacturing technology has come a long way in recent years, and there are now a variety of different ways to produce high-quality softgels. This has led to increased efficiency and lower costs, making softgels more affordable for both manufacturers and consumers.
4. New and innovative uses for softgels: Softgels are being used for a variety of new and innovative applications, such as delivery of nutraceuticals, cosmetics, and even vaccines. This is opening up new markets for softgel manufacturers and providing more options for consumers.
Key Drivers
The key drivers of the softgel capsules market are the rising demand for dietary supplements and the growing pharmaceutical industry. The increasing health consciousness among people and the rising incidence of chronic diseases are also driving the growth of the market. Moreover, the easy availability of softgel capsules and the increasing number of manufacturing companies are providing a boost to the market growth. However, the high cost of softgel capsules and the stringent regulations imposed by the government are restraining the market growth.
Restraints & Challenges
One of the key restraints in the softgel capsules market is the stringent regulations associated with the approval of new drugs. The introduction of a new drug in the market is a lengthy and complicated process, which requires pre-clinical and clinical trials. This is a time-consuming and expensive process, which acts as a restraint for the growth of the softgel capsules market.
Another restraint in the softgel capsules market is the high cost of these drugs. The cost of developing a new drug is very high, which limits the number of new drugs that can be introduced in the market. This, in turn, hampers the growth of the softgel capsules market.
The key challenge in the softgel capsules market is the increasing competition from generic drugs. Generic drugs are available at a lower price than branded drugs, which makes them more affordable for patients. This is a challenge for the growth of the softgel capsules market as it leads to a decline in the sales of branded drugs.
Market Segments
The Softgel Capsules Market is segmented based on application, sales channel, and region. Based on application, the market is bifurcated as health supplements and pharmaceuticals. According to the sales channel, it is categorized into supermarket & hypermarket, pharmacy & drug store, and online provider. Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
The Softgel Capsules Market report includes players such as BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsules Co., Ltd., InovoBiologic Inc., NOW Foods Inc., Sirio Pharma Co., Ltd., Super Spectrim, Thermo Fisher Scientific, Inc. (Patheon), and Trigen Laboratories, Inc.
Table of Contents
Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Softgel Capsules Market Outlook
3.1. Softgel Capsules Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Softgel Capsules Market
Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Softgel Capsules Market
4.3. Economic Impact Analysis
Chapter 5. Softgel Capsules Market By Sales Channel
5.1. Market Overview
5.2. Health Supplements
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Pharmaceuticals
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 6. Softgel Capsules Market By Sales Channel
6.1. Market Overview
6.2. Supermarket and Hypermarket
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Pharmacy and Drug Store
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Online Provider
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 7. Softgel Capsules Market, by region
7.1. Overview
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. North America Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.2.3. North America Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.2.4. The U.S.
7.2.4.1. The U.S. Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.2.4.2. The U.S. Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.2.5. Canada
7.2.5.1. Canada Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.2.5.2. Canada Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.2.6. Mexico
7.2.6.1. Mexico Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.2.6.2. Mexico Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Europe Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.3. Europe Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.4. Germany
7.3.4.1. Germany Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.4.2. Germany Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.5. France
7.3.5.1. France Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.5.2. France Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.6. U.K.
7.3.6.1. U.K. Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.6.2. U.K. Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.7. Spain
7.3.7.1. Spain Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.7.2. Spain Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.8. Italy
7.3.8.1. Italy Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.8.2. Italy Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.9. Rest of Europe
7.3.9.1. Rest of Europe Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.3.9.2. Rest of Europe Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Asia-Pacific Softgel Capsules Market Size and Forecast by Country, 2021-2031, ($Million)
7.4.3. Asia-Pacific Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.4. China
7.4.4.1. China Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.4.2. China Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.5. India
7.4.5.1. India Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.5.2. India Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.6. Japan
7.4.6.1. Japan Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.6.2. Japan Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.7. South Korea
7.4.7.1. South Korea Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.7.2. South Korea Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.8. Rest of APAC
7.4.8.1. Rest of APAC Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.4.8.2. Rest of APAC Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.5. Rest of the World
7.5.1. Key Market Trends and Opportunities
7.5.2. Rest of the World Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.5.3. Rest of the World Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.5.4. Latin America
7.5.4.1. Latin America Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.5.4.2. Latin America Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.5.5. Middle East
7.5.5.1. Middle East Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.5.5.2. Middle East Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.5.6. Africa
7.5.6.1. Africa Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
7.5.6.2. Africa Softgel Capsules Market Size and Forecast By Sales Channel, 2021-2031, ($Million)
Chapter 8. Competitive Landscape
8.1. Market Overview
8.2. Market Share Analysis/Key Player Positioning
8.3. Developmental Strategy Benchmarking
8.3.1. New Product Development
8.3.2. Product Launches
8.3.3. Business Expansions
8.3.4. Partnerships, Joint Ventures, and Collaborations
8.3.5. Mergers and Acquisitions
Chapter 9. Company Profiles
9.1. BASF SE
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Offerings
9.1.4. Key Strategic Initiatives
9.1.5. SWOT Analysis
9.2. Catalent, Inc
9.2.1. Company Snapshot
9.2.2. Financial Performance
9.2.3. Product offerings
9.2.4. Key Strategic Initiatives
9.2.5. SWOT Analysis
9.3. Colorcon Inc.
9.3.1. Company Snapshot
9.3.2. Financial Performance
9.3.3. Product offerings
9.3.4. Key Strategic Initiatives
9.3.5. SWOT Analysis
9.4. Fuji Capsules Co., Ltd.
9.4.1. Company Snapshot
9.4.2. Financial Performance
9.4.3. Product offerings
9.4.4. Key Strategic Initiatives
9.4.5. SWOT Analysis
9.5. InovoBiologic Inc
9.5.1. Company Snapshot
9.5.2. Financial Performance
9.5.3. Product offerings
9.5.4. Key Strategic Initiatives
9.5.5. SWOT Analysis
9.6. NOW Foods Inc
9.6.1. Company Snapshot
9.6.2. Financial Performance
9.6.3. Product offerings
9.6.4. Key Strategic Initiatives
9.6.5. SWOT Analysis
9.7. Sirio Pharma Co., Ltd
9.7.1. Company Snapshot
9.7.2. Financial Performance
9.7.3. Product offerings
9.7.4. Key Strategic Initiatives
9.7.5. SWOT Analysis
9.8. Super Spectrim l
9.8.1. Company Snapshot
9.8.2. Financial Performance
9.8.3. Product offerings
9.8.4. Key Strategic Initiatives
9.8.5. SWOT Analysis
9.9. Thermo Fisher Scientific, Inc. (Patheon)
9.9.1. Company Snapshot
9.9.2. Financial Performance
9.9.3. Product offerings
9.9.4. Key Strategic Initiatives
9.9.5. SWOT Analysis
9.10. Trigen Laboratories, Inc
9.10.1. Company Snapshot
9.10.2. Financial Performance
9.10.3. Product offerings
9.10.4. Key Strategic Initiatives
9.10.5. SWOT Analysis
*The list of company is subject to change during the final compilation of the report
Key Players
Market Segments
- By Application
- Health Supplements
- Pharmaceuticals
- By Sales Channel
- Supermarket & Hypermarket
- Pharmacy & Drug store
- Online Provider
- By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The UK
- Germany
- France
- Spain
- Rest of Europe
- The Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa
- North America